we talked about it for namenda. combination pill for ara sent, the only other drug approved for alzheimer's and namenda coming out in 2015. liz: they're committed to the path you started? >> they are. they are absolutely committed to invest and have durable portfolio and look for innovation to help patients. >> as we leave, you will have seat on combined company board? >> that is correct. liz: you had a short-lived seat on this one. >> i'm very committed to the combination. we'll see how things work out. liz: i'm sure uncle carl is looking for your next opportunity. you've been a great leader. >> thank you, liz. liz: brent saunders, forest labs ceo and president. company will double spending on research to look into other drugs. david: thank god they're continuing to look into alzheimer's. for carl icahn to hold on to a stock for three years he is a believer. alan blinder is a believer as well. former vice-chair of the federal reserve. one of the most distinguished economists of his generation. he is wading into the